Candel Therapeutics, Inc. (CADL) has 41 open-market insider trades by 13 insiders since 2021. The most active filer is Paul Peter Tak, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Paul B. Manning | Dir | — | 4 | $23.8M | 2026-02-23 |
| Paul Peter Tak | CEO | — | 7 | $1.9M | 2026-09-11 |
| Christopher Martell | Dir | — | 2 | $1.1M | 2025-06-25 |
| Seshu Tyagarajan | CTO | — | 6 | $1.0M | 2026-08-17 |
| Francesca Barone | CSO | — | 6 | $957K | 2026-06-29 |
| William Garrett Nichols | — | — | 5 | $713K | 2025-07-28 |
| Estuardo Aguilar-Cordova | 10% Owner | — | 2 | $692K | 2025-02-21 |
| Charles Schoch | — | — | 4 | $536K | 2025-06-25 |
| Joseph C. Papa | Dir | — | 1 | $141K | 2025-06-25 |
| John J. Canepa | CFO | — | 1 | $81K | 2021-07-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Paul Peter Tak | CEO | Sell | $3.2M | 2026-09-10 |
| Seshu Tyagarajan | CTO | Sell | $84K | 2026-08-17 |
| Seshu Tyagarajan | CTO | Sell | $70K | 2026-06-29 |
| Francesca Barone | CSO | Sell | $236K | 2026-06-29 |
| Paul B. Manning | Director | Buy | $3.0M | 2026-02-23 |
| William Garrett Nichols | Chief Medical Officer | Sell | $7K | 2025-07-28 |
Companies that share insiders with CADL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| William Garrett Nichols | Chief Medical Officer | Sell | $4K | 2025-06-30 |
| William Garrett Nichols | — | Sell | $794K | 2025-03-18 |
| Francesca Barone | CSO | Sell | $563K | 2025-03-18 |
| Paul Peter Tak | CEO | Sell | $456K | 2025-03-18 |
| Charles Schoch | — | Sell | $44K | 2025-03-17 |
| Seshu Tyagarajan | CTO | Sell | $552K | 2025-03-17 |
| Paul Peter Tak | CEO | Sell | $314K | 2025-01-15 |
| Seshu Tyagarajan | CTO | Sell | $207K | 2025-01-15 |
| William Garrett Nichols | — | Sell | $151K | 2025-01-15 |